Monday, 7 October 2024
  
Login

Australia's most trusted
source of pharma news

Monday, 07 October 2024
News

New guide probes ADHD drugs

Posted 1 October 2024 AM

HCPs involved in the controversial issue of prescribing for ADHD are endeavouring to address what they describe as "significant variability in ADHD prescribing across the country" with the publication of Australia's first prescribing guide for the condition.

The Australasian ADHD Professionals Association (AADPA) says its new guide "delivers clear and consistent information on the pharmacological treatment of ADHD across different age groups and settings".

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (6)

Sales & Customer Relations (15)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (6)

Other (13)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.